Parenteral ω-3 fatty acid lipid emulsions for children with intestinal failure and other conditions: A systematic review

Journal of Parenteral and Enteral Nutrition

Volumn 37, Issue 1, 2013, Pages 44-55

  Seida, Jennifer C ^a   Mager, Diana R ^b   Hartling, Lisa ^a   Vandermeer, Ben ^a   Turner, Justine M ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

3 fatty acids; intestinal failure; n 3; parenteral nutrition; systematic review

Indexed keywords

C REACTIVE PROTEIN; CLINOLEIC; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID EMULSION; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID; OMEGAVEN; PREALBUMIN; RETINOL BINDING PROTEIN; SERUM ALBUMIN; TRIACYLGLYCEROL;

ARTIFICIAL VENTILATION; BIRTH WEIGHT; BRAIN HEMORRHAGE; COGNITIVE DEVELOPMENT; HEART DISEASE; HEMATOCRIT; HOSPITALIZATION; HUMAN; INTESTINAL FAILURE; LEUKOCYTE; LIVER TRANSPLANTATION; LOW BIRTH WEIGHT; META ANALYSIS (TOPIC); MORTALITY; PATENT DUCTUS ARTERIOSUS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTHROMBIN TIME; QUALITY CONTROL; RETINOPATHY; REVIEW; SYSTEMATIC REVIEW; TRIACYLGLYCEROL BLOOD LEVEL;

DIETARY FATS; FAT EMULSIONS, INTRAVENOUS; FATTY ACIDS, OMEGA-3; HEART DISEASES; HUMANS; INTESTINAL DISEASES; LIVER DISEASES; PARENTERAL NUTRITION;

EID: 84872100118     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607112450300     Document Type: Review

References (36)

1. Calder P.. n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr. 2006 ; 83 (6). 1505S - 1519S
2. Aterburn L, Bailey Hall E, Oken H.. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr. 2006 ; 83: 1467S - 14676S
3. Diamond IR, de Silva NT, Tomlinson GA, et al. The role of parenteral lipids in the development of advanced intestinal failure-associated liver disease in infants: a multiple-variable analysis. JPEN J Parenter Enteral Nutr. 2011 ; 35: 596-602
4. Wales P, de Silva N, Kim J, Leece L, To T, Moore A.. Neonatal short bowel syndrome: population-based estimates of incidence and mortality rates. J Pediatr Surg. 2004 ; 39: 690-695
5. Fecteau A, Atkinson P, Grant D.. Early referral is essential for successful pediatric small bowel transplantation: the Canadian experience. J Pediatr Surg. 2001 ; 36 (5). 381-384
6. Diamond IR, Sterescu A, Pencharz PB, Wales PW.. The rationale for the use of parenteral omega-3 lipids in children with short bowel syndrome and liver disease. Pediatr Surg Int. 2008 ; 24: 773-778
7. Puder M, Valim C, Meisel JA, et al. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg. 2009 ; 250 (3). 395-402
8. Larsen BMK, Goonewardene LA, Joffe AR, et al. Pre-treatment with an intravenous lipid emulsion containing fish oil (eicosapentaenoic and docosahexaenoic acid) decreases inflammatory markers after open-heart surgery in infants: a randomized, controlled trial. Clin Nutr. :
9. Fallon E, Le H, Puder M.. Prevention of parenteral nutrition-associated liver disease: role of omega-3 fish oil. Curr Opin Organ Transplant. 2010 ; 15: 334-340
10. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. Higgins J Green S, ed. New York: John Wiley ; 2008 :
11. Wells G, Shea B, O'Connell N, et al The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta-Analyses. Ottawa, Canada: Department of Epidemiology and Community Medicine, University of Ottawa ; 2009 :
12. Sismondo S.. Pharmaceutical company funding and its consequences: a qualitative systematic review. Contemp Clin Trials. 2008 ; 29: 109-113
13. Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004 1490 ; 328 ( 7454 ):
14. Guyatt G, Gutterman D, Baumann MH, et al. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians Task Force. Chest. 2006 ; 129 (1). 174-181
15. Greenland S, Robins JM.. Estimators of the Mantel-Haenszel variance consistent in both sparse data and large-strata limiting models. Biometrics. 1985 ; 42: 311-323
16. Gura KM, Lee S, Valim C, et al. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics. 2008 ; 121 (3). e678 - e686
17. Lee SI, Valim C, Johnston P, et al. Impact of fish oil-based lipid emulsion on serum triglyceride, bilirubin, and albumin levels in children with parenteral nutrition-associated liver disease. Pediatr Res. 2009 ; 66 (6). 698-703
18. Goulet O, Antebi H, Wolf C, et al. A new intravenous fat emulsion containing soybean oil, medium-chain triglycerides, olive oil, and fish oil: a single-center, double-blind randomized study on efficacy and safety in pediatric patients receiving home parenteral nutrition. JPEN J Parenter Enteral Nutr. 2010 ; 34 (5). 485-495
19. Pawlik D, Lauterbach R, Turyk E.. Fish-oil emulsion supplementation may reduce the risk of severe retinopathy in VLBW infants. Pediatrics. 2011 ; 127: 223-228
20. Rayyan M, Devlieger H, Jochum F, Allegaert K.. Short-term use of parenteral nutrition with a lipid emulsion containing a mixture of soybean oil, olive oil, medium-chain triglycerides, and fish oil: a randomized, double-blind study in preterm infants. JPEN J Parenter Enteral Nutr. 2012 ; 36: 81S - 94S
21. Skouroliakou M, Konstantinou D, Koutri K, et al. A double-blind, randomized clinical trial of the effect of omega-3 fatty acids on the oxidative stress of preterm neonates fed through parenteral nutrition. Eur J Clin Nutr. 2010 ; 64 (9). 940-947
22. Tomsits E, Pataki M, Tolgyesi A, Fekete G, Rischak K, Szollar L.. Safety and efficacy of a lipid emulsion containing a mixture of soybean oil, medium-chain triglycerides, olive oil, and fish oil: a randomised, double-blind clinical trial in premature infants requiring parenteral nutrition. J Pediatr Gastroenterol Nutr. 2010 ; 51 (4). 514-521
23. Wirtitsch M, Wessner B, Spittler A, et al. Effect of different lipid emulsions on the immunological function in humans: a systematic review with meta-analysis. Clin Nutr. 2007 ; 26 (3). 302-313
24. Jurewitsch B, Gardiner G, Naccarato M, Jeejeebhoy KN.. Omega-3-enriched lipid emulsion for liver salvage in parenteral nutrition-induced cholestasis in the adult patient. JPEN J Parenter Enteral Nutr. 2011 ; 35 (3). 386-390
25. Teitelbaum DH, Tracy T.. Parenteral nutritional-associated cholestasis. Semin Pediatr Surg. 2001 ; 10 (2). 72-80
26. Kelly DA.. Intestinal failure-associated liver disease: what do we know today?. Gastroenterology. 2006 ; 130 (2). S70 - S77
27. Cowles RA, Ventura KA, Martinez M, et al. Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation. J Pediatr Surg. 2010 ; 45: 84-88
28. Cober MP, Teitelbaum DH.. Prevention of parenteral nutrition-associated liver disease: lipid minimization. Curr Opin Organ Transplant. 2010 ; 15 (3). 330-333
29. El Kasmi KC, Anderson A, Devereaux MW, Noe MS, Sokol RJ.. Soy lipid-derived phytosterols are responsible for parenteral nutritional associated liver injury (PNALI) in a mouse model. Presented at: The 62nd Annual Meeting of the American Association for the Study of Liver Diseases ; San Francisco, CA ;..
30. Biesalski HK.. Vitamin E requirements in parenteral nutrition. Gastroenterology. 2009 ; 137: S92 - S104
31. Linseisen J, Hoffmann J, Lienhard S, Jauch KW, Wolfram G.. Antioxidant status of surgical patients receiving TPN with an omega-3-fatty acid-containing lipid emulsion supplemented with alpha-tocopherol. Clin Nutr. 2000 ; 19 (3). 177-184
32. Soden J, Lovell M, Brown K, Partrick D, Sokol R.. Failure of resolution of portal fibrosis during omega-3 fatty acid lipid emulsion therapy in two patients with irreversible intestinal failure. J Pediatr. 2010 ; 156 (2). 327-331
33. Fitzgibbons SC, Jones BA, Hull MA, et al. Relationship between biopsy-proven parenteral nutrition-associated liver fibrosis and biochemical cholestasis in children with short bowel syndrome. J Pediatr Surg. 2010 ; 45: 95-99
34. Dicken B, Huynh H, Turner J.. More evidence on the use of parenteral omega-3 lipids in pediatric intestinal failure. J Pediatr. 2011 ; 159 (1). 170-171
35. Clandinin MT, Van Aerde JE, Merkel KL, et al. Growth and development of preterm infants fed infant formulas docosahexaenoic acid and arachidonic acid. J Pediatr. 2005 ; 146 (4). 461-468
36. Simmer K, Patole SK, Rao SC.. Longchain polyunsaturated fatty acid supplementation in infants born at term. Cochrane Database Syst Rev. 2008 ; 23 ( 1 ):